The Roche Investor Relations team would like to invite you to Roche’s Virtual Pharma Day 2021 that will take place as a live webinar on Tuesday, 14th September 2021 14:00 – 17:00 CEST / 13:00 - 16:00 BST 8:00 – 11:00 am EDT / 5:00 - 8:00 am PDT The webinar will start with presentations, followed by a Q&A session.   Pharma strategy, Culture and organization, New technologies Market opportunities, Launches, Commercial model & Access Late stage pipeline: Oncology, Neuroscience, Immunology, Ophthalmology, Infectious diseases Presenters: Bill Anderson, Chief Executive Officer Roche Pharmaceuticals Teresa Graham, Head of Pharma Global Product Strategy Levi Garraway, Chief Medical Officer and Head Global Product Development Paulo Fontoura, Global Head of Neuroscience, Immunology, Ophthalmology, Infectious and Rare Diseases, Clinical Development Nilesh Mehta, Life Cycle Leader Faricimab Barry Clinch, Global Head Infectious Diseases, Clinical Development   We would like to invite all interested parties to participate in the webinar and to pre-register here.* Should you be unable to register for the webinar due to your company IT policy, please send an email to investor.relations@roche.com. A replay of the event will be available via > ir.roche.com *privacy notice
Best regards, Karl Mahler Head of Investor Relations	Bruno Eschli Investor Relations Officer
Roche Investor Relations
Dr. Karl Mahler Phone: +41 61 68-78503 e-mail: karl.mahler@roche.com	Jon Kaspar Bayard Phone: +41 61 68-83894 e-mail: jon_kaspar.bayard@roche.com
Dr. Sabine Borngräber Phone: +41 61 68-88027 e-mail: sabine.borngraeber@roche.com	Dr. Bruno Eschli Phone: +41 61 68-75284 e-mail: bruno.eschli@roche.com
Dr. Birgit Masjost Phone: +41 61 68-84814 e-mail: birgit.masjost@roche.com	Dr. Gerard Tobin Phone: +41 61 68-72942 e-mail: gerard.tobin@roche.com
Investor Relations North America
Loren Kalm Phone: +1 650 225 3217 e-mail: kalm.loren@gene.com

get the latest news and updates to your inbox.